Studies related to HbA1c and Tetradecyl Thioacetic Acid

Tetradecylthioacetic Acid Attenuates Dyslipidaemia In Male Patients With Type 2 Diabetes Mellitus, Possibly By Dual PPAR-alpha/delta Activation And Increased Mitochondrial Fatty Acid Oxidation

Effect None
Trial Design Cohort
Trial Length 2-4 Weeks
Number of Subjects 16
Sex Male
Age Range 30-44, 45-64
Body Types Obese
Notes for this study:
1g of TTA taken daily for 28 days in an open-labelled study, decreases in LDL and increases in HDL apolipoproteins was seen; a drop in diastolic blood pressure (from 88 to 83) was seen despite systolic remaining static (136 to 133). Weight was not decreased when diet was not controlled.

Full details on all 2 studies are available to Examine Plus members.

Already a member? Login now to access.